长江商报消息 合成生物龙头企业华恒生物（688639.SH）将赴港IPO。 7月30日晚间，华恒生物发布公告，公司正在筹划发行境外股份（H股）并在香港联合交易所有限公司 （以下简称"香港联交所"）上市事宜，以深入推进全球化战略，全面提升综合实力。 长江商报记者注意到，作为国内生物发酵领域的技术领先企业，近年来华恒生物积极开拓境外客户，发 展海外市场。2024年，华恒生物在境外市场实现营业收入10.32亿元，同比增长30.34%，占营业收入的 比例达到47.4%。 然而，在市场竞争加剧，主要产品价格大降的背景下，华恒生物业绩承压。2024年二季度至2025年一季 度，华恒生物已连续四个季度增收不增利。2024年，公司产品毛利率为24.92%，同比下降15.6个百分 点。 值得关注的是，筹划赴港方式拓宽融资渠道数月前，华恒生物刚刚完成一笔再融资。 资料显示，2021年4月，华恒生物在科创板上市，首发价格为23.16元/股，募集资金总额6.25亿元，扣除 相关费用后的募资净额约为5.59亿元。 7月30日晚间，华恒生物公告，公司目前正在筹划境外发行股份（H股）并在香港联交所上市事宜，公 司正与相关中介机构就本次H股 ...

全球政策进展 | 工信部 【DT新材料】 获 悉，7月 31日， 工业和信息化部消费品工业司正式公示了 "生物制造标志性产品 名单（第一批）" ，共36项产品入选 。这一举措标志着我国生物制造领域在技术创新和产业升级方 面迈出了重要一步，也体现了国家对生物制造产业发展的高度重视和积极推动。 "生物制造标志性产品名单（第一批）"涉及到 36家企业，分别是： 首朗生物、微元合成、微构工 场、合源生物、凯莱英、秦皇岛华恒生物、神舟生物、金宇保灵生物、齐鲁制药、金赛药业、黑龙江 新和成、凯赛生物、昌进生物、蓝晶微生物、轩凯生物、温州医科大学细胞生长因子药物和蛋白制剂 国家工程研究中心、海正药业、华恒生物、万泰沧海生物、富祥生物、华熙生物、润德生物、中科院 青岛能源所、金丹乳酸、禾元生物、嘉必优、安琪酵母、利尔生物、康方药业、汉和生物、庆智翔金 泰生物、康弘药业、沃森生物、中国医学科学院医学生物学研究所、川宁生物、天康生物制药 。 生物制造标志性产品名单（第一批） ▼▼▼ | | | | | 乙醇梭菌 | 北京首朗 | 食品、饲 | | 乙醇梭菌蛋白是经微生物发酵、提取生产的蛋白质。本 | | --- | --- | ...

华恒生物表示，此举有利于深入推进公司全球化发展战略，提升品牌影响力与核心竞争力，巩固行业领 先地位。并充分借助国际资本市场的资源与机制优势，优化资本结构，拓宽多元融资渠道，全面提升公 司治理水平和综合实力。 （文章来源：证券日报） 本报讯 （记者徐一鸣）7月30日，安徽华恒生物科技股份有限公司（以下简称"华恒生物"）发布公告 称，公司正在筹划发行境外股份（H股）并在香港联合交易所有限公司上市事宜。 ...

中国经济网北京7月31日讯华恒生物（688639.SH）昨晚发布关于筹划公司在香港联合交易所有限公司 上市的提示性公告。 华恒生物为深入推进公司全球化发展战略，提升品牌影响力与核心竞争力，巩固行业领先地位，充分借 助国际资本市场的资源与机制优势，优化资本结构，拓宽多元融资渠道，全面提升公司治理水平和综合 实力，正在筹划发行境外股份（H股）并在香港联合交易所有限公司（以下简称"香港联交所"）上市事 宜（以下简称"本次H股上市"）。公司正与相关中介机构就本次H股上市的具体推进工作进行商讨，相 关细节尚未确定，本次H股上市不会导致公司控股股东和实际控制人发生变化。 华恒生物于2021年4月22日在上交所科创板上市，保荐机构为兴业证券股份有限公司，保荐代表人为黄 超、饶毅杰。华恒生物公开发行募集资金总额为62532.00万元，募集资金净额为55925.88万元。华恒生 物于2021年4月16日披露的招股书显示，公司募集资金5.71亿元，分别用于交替年产2.5万吨丙氨酸、缬 氨酸项目、发酵法丙氨酸5000吨/年技改扩产项目、补充流动资金。 根据中国证券监督管理委员会出具的《关于同意安徽华恒生物科技股份有限公司向特定对象 ...

Group 1 - As of July 30, 2025, Huaheng Biological's stock price is 33.77 yuan, down 0.74 yuan or 2.14% from the previous trading day [1] - The trading volume on the same day was 54,947 hands, with a transaction amount of 188 million yuan [1] - Huaheng Biological operates in the chemical products industry, focusing on the research, production, and sales of amino acids and their derivatives, which are widely used in food, pharmaceuticals, and feed sectors [1] Group 2 - The company is planning to issue overseas shares and list on the Hong Kong Stock Exchange, with details yet to be determined [1] - This issuance will not change the company's controlling shareholder or actual controller [1] - As of July 30, 2025, the net outflow of main funds for Huaheng Biological was 6.0878 million yuan, accounting for 0.07% of the circulating market value [1]

本次 H 股上市能否通过审议、备案和审核程序并最终实施具有较大不确定性。 公司将依据相关法律法规的规定，根据本次 H 股上市的后续进展情况及时履行信 息披露义务。本次 H 股上市尚存在较大不确定性，敬请广大投资者理性投资，注 意投资风险。 特此公告。 提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 安徽华恒生物科技股份有限公司（以下简称"公司"）为深入推进公司全球 化发展战略，提升品牌影响力与核心竞争力，巩固行业领先地位，充分借助国际 资本市场的资源与机制优势，优化资本结构，拓宽多元融资渠道，全面提升公司 治理水平和综合实力，正在筹划发行境外股份（H 股）并在香港联合交易所有限 公司（以下简称"香港联交所"）上市事宜（以下简称"本次 H 股上市"）。公司 正与相关中介机构就本次 H 股上市的具体推进工作进行商讨，相关细节尚未确定， 本次 H 股上市不会导致公司控股股东和实际控制人发生变化。 根据《中华人民共和国公司法》《中华人民共和国证券法》《上海证券交易所 科创板股票上市规则》《境内企业境外发行证券和上市管理 ...

Investment Rating - Industry Rating: Neutral (maintained rating) [6] Core Viewpoints - The report highlights the recent price increases in key chemical products such as soda ash, organic silicon, and MDI, driven by strong demand and supply constraints [1][3] - The basic chemical sector outperformed the Shanghai and Shenzhen 300 index, with a weekly increase of 4.25% compared to 1.69% for the index, indicating a positive market sentiment [4][16] - The report suggests that the industry may be at a cyclical bottom, with a focus on supply-demand marginal changes [5] Summary by Sections Key News Tracking - The National Development and Reform Commission issued a revised method for energy consumption and carbon emission management for fixed asset investment projects, which is expected to enhance energy efficiency reviews [1][13] Product Price Monitoring - Key chemical products saw significant price changes, with organic silicon and TDI prices increasing by 11.6% and 6.8% respectively, while DMF and acetic acid prices decreased by 5.7% and 1.3% [2][26] - The report notes that 85 out of 345 tracked chemical products experienced price increases, while 79 saw declines [26] Sector Performance - The basic chemical sector's weekly performance was strong, with notable increases in synthetic resin (+21.94%), soda ash (+14.45%), and organic silicon (+9.01%) [4][18] - The report lists the top-performing stocks in the basic chemical sector, with significant gains for companies like Shangwei New Materials (+97.37%) and Henghe Precision (+64.42%) [21] Investment Insights - The report recommends focusing on sectors with stable demand and potential for recovery, such as organic silicon and amino acids, while also highlighting companies that may benefit from domestic demand [5][6] - It emphasizes the importance of supply-side reforms and cost factors in pricing strategies to mitigate market volatility [5]

Investment Rating - The report maintains a positive outlook on the pesticide industry, suggesting a "Buy" rating for key companies such as Yangnong Chemical, Lier Chemical, and Runfeng Shares [3][20]. Core Insights - The pesticide industry is experiencing a recovery due to the "Zhengfeng Zhijuan" initiative aimed at regulating the market, which has led to price increases for key products like fluorocarbon herbicides [3][4]. - The report highlights the impact of maintenance shutdowns at major production facilities, such as Wanhua's Hungarian plant, which may lead to supply shortages and price increases in the TDI market [3][4]. - The report emphasizes the potential for improved industry dynamics through the elimination of outdated production capacity, as indicated by government initiatives targeting key sectors [3][4]. Summary by Sections Industry Dynamics - Current macroeconomic conditions indicate a stable global GDP growth of 2.8%, with oil demand expected to rise despite some slowdown due to tariffs [4]. - The report notes that coal prices are expected to decline in the medium to long term, alleviating pressure on downstream industries [4]. Chemical Prices - Recent price movements include a 15% increase in the price of Lier Chemical's fluorocarbon herbicide and a similar rise for Zhongqi Shares [3][11]. - The report mentions that the price of TDI is expected to rise due to low global inventory levels and potential supply disruptions from maintenance activities [3][4]. Investment Recommendations - The report suggests focusing on traditional cyclical stocks and specific sectors such as coal chemical, real estate chain, and agricultural chemicals, highlighting companies like Wanhua Chemical and Hualu Hengsheng [3][20]. - Growth stocks with recovery potential are identified, including semiconductor materials and OLED panel materials, with specific companies recommended for investment [3][20].

Investment Rating - The report maintains a positive outlook on the chemical industry, with specific buy and hold recommendations for various companies [2][20]. Core Insights - The report highlights the closure of Dow's organic silicon production capacity in Barry, UK, which is expected to increase domestic export demand and support the upstream industrial silicon costs, indicating a potential reversal in the organic silicon industry [4][5]. - The demand for high-end AI PCBs is projected to surge due to the continuous growth in computing power requirements, driven by GPU, ASIC, and 800G switch technologies [4]. - The report notes that the recent tariff announcements from the US on imports from Southeast Asia are lower than expected, stabilizing pessimistic market sentiments [4]. Industry Dynamics - The macroeconomic outlook for the chemical industry indicates a significant increase in oil supply led by non-OPEC countries, with a stable global GDP growth rate of 2.8% [5]. - The report mentions that coal prices are expected to decline in the medium to long term, alleviating pressure on downstream sectors [5]. - Natural gas exports from the US are anticipated to accelerate, potentially lowering import costs [5]. Company Recommendations - Companies to watch in the organic silicon sector include Dongyue Silicon Materials, Xin'an Chemical, and Xingfa Group [4]. - In the PCB sector, recommended companies include Shengquan Group, Dongcai Technology, Lianrui New Materials, Yake Technology, Tiancheng Technology, and Jiuri New Materials [4]. - For traditional cyclical stocks, the report suggests focusing on leading companies in various segments such as Wanhu Chemical, Hualu Hengsheng, and Baofeng Energy [4]. Price Trends - The report provides specific price movements for various chemical products, such as PTA prices decreasing by 2.8% to 4715 RMB/ton, while MEG prices increased by 0.7% to 4409 RMB/ton [11]. - Urea prices rose by 2.9% to 1800 RMB/ton, while phosphate prices remained stable [12]. - The report notes that the price of DMC increased by 1.9% to 11000 RMB/ton, indicating a recovery in the organic silicon market [15].

Core Viewpoint - The company announced a cash dividend of 0.25 yuan per share, approved at the 2024 annual general meeting held on May 13, 2025 [1]. Summary by Relevant Sections Dividend Distribution Plan - The company plans to distribute a cash dividend of 2.50 yuan (including tax) for every 10 shares held, with no capital reserve transfer or bonus shares issued [2]. - The total number of shares eligible for the dividend distribution is 249,619,093 shares after excluding 496,600 shares held in the repurchase account [2]. - The total cash dividend to be distributed amounts to approximately 62,404,773.25 yuan (including tax) [2]. Ex-Dividend Calculation - The ex-dividend reference price is calculated as (previous closing price - 0.2495 yuan) [4]. - The cash dividend per share is approximately 0.2495 yuan after adjusting for the total shares participating in the distribution [4]. Implementation Details - Shares held in the repurchase account will not participate in the profit distribution or capital increase [5]. - Cash dividends will be distributed through the China Securities Depository and Clearing Corporation Limited Shanghai Branch to shareholders registered by the end of the trading day on the record date [5]. Taxation Information - For individual shareholders holding unrestricted shares for over one year, the dividend income is exempt from personal income tax, resulting in a net cash dividend of 0.25 yuan per share [7]. - For shares held for one year or less, the company will not withhold personal income tax at the time of distribution, but tax will be calculated upon the sale of the shares [7]. - For qualified foreign institutional investors (QFII), a 10% withholding tax will apply, resulting in a net cash dividend of 0.225 yuan per share [9]. Contact Information - For inquiries regarding the dividend distribution, shareholders can contact the Securities Investment Department at 0551-65689046 [10].